National Comprehensive Cancer Network



About NCCN

Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel - Disclosures as of 5/22/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Wallace Akerley, MD

Bristol-Myers Squibb Company;
Daiichi- Sankyo Co.;
Genentech, Inc.

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
BioMarin;
Biotheranostics;
Clarient Consulting

None

None

3/5/2013

Hossein Borghaei, DO, MS

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.

Amgen Inc.;
Genentech, Inc.

None

None

7/2/2012

Andrew C. Chang, MD

None

None

None

None

5/15/2013

Richard T. Cheney, MD

None

OptumHealth

None

None

7/3/2012

Lucian R. Chirieac, MD

None

Boehringer Ingelheim GmbH;
Aposense;
Infinity;
Shook,Hardy&Bacon

None

None

5/1/2012

Thomas A. D'Amico, MD

None

Scanlan

None

None

2/28/2013

Todd L. Demmy, MD

None

None

None

None

10/12/2012

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix;
Gilead;
Roche Laboratories, Inc.

None

None

2/28/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Ramaswamy Govindan, MD

None

AstraZeneca Pharmaceuticals LP;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Covidien AG;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.

None

None

3/28/2012

Frederic W. Grannis, MD

None

Steven Phillips (sphillips@lpklaw.com)

None

City of Hope National Medical Center Board of Directors

6/18/2012

Stefan C. Grant, MD, JD

None

None

None

None

5/14/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Leora Horn, MD, MSc, FRCPC

Boehringer Ingelheim GmbH

Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

8/16/2012

Miranda Hughes, PhD

None

None

None

None

4/10/2013

Thierry M. Jahan, MD

Abbott Laboratories;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
Morphotek Inc.;
Aduro Pharmaceuticals;
Merrimack pharmaceuticals

None

None

Novartis Pharmaceuticals Corporation

4/16/2013

Ritsuko Komaki, MD

Pfizer Inc.

None

None

None

7/3/2012

Feng-Ming (Spring) Kong, MD, PhD

None

None

None

None

10/9/2012

Mark G. Kris, MD

Boehringer Ingelheim GmbH;
Pfizer Inc.

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Bind Biosciences;
Clovis Oncology, Inc;
Esanex, Inc;
Roche Laboratories, Inc.

None

None

3/4/2013

Lee M. Krug, MD

Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
CanBas

Genentech, Inc.;
MedImmune Inc.;
Morphotek Inc.

None

None

6/18/2012

Rudy P. Lackner, MD

None

None

None

None

3/2/2013

Inga T. Lennes, MD

None

None

None

None

6/18/2012

Billy W. Loo, MD, PhD

None

None

None

Siemens Medical Solutions Diagnostics;
Varian Medical Systems, Inc.

3/20/2013

Christine M. Lovly, MD, PhD

None

Clinvaluate

None

None

2/26/2013

Renato Martins, MD, MPH

Bayer HealthCare;
Eisai Inc.;
Exelixis Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

4/8/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

Gregory A. Otterson, MD

Abraxis Oncology;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.;
Pharmacyclics

Abraxis Bioscience, Inc.;
Genentech, Inc.

None

None

1/23/2013

Jyoti D. Patel, MD

Eli Lilly and Company

Genentech, Inc.

None

None

3/26/2012

Mary C. Pinder-Schenck, MD

Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.;
Pfizer Inc.

None

None

None

7/3/2012

Katherine M. Pisters, MD

None

None

None

None

4/10/2013

Karen Reckamp, MD, MS

Amgen Inc.;
Bristol-Myers Squibb Company;
GlaxoSmithKline;
Astelles;
Pfizer Inc.

Amgen Inc.

None

None

3/5/2013

Gregory J. Riely, MD, PhD

GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Chugai;
Infinity Pharmaceuticals

Celgene Corporation;
Daiichi- Sankyo Co.;
Chugai

None

None

8/16/2012

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Theresa A. Shapiro, MD, PhD

None

None

None

None

5/4/2012

Scott Swanson, MD

None

Covidien AG;
Ethicon, Inc.

None

None

7/5/2012

Kurt Tauer, MD

None

Eli Lilly and Company

None

None

7/5/2012

Douglas E. Wood, MD

None

Lung Cancer Alliance

None

None

5/11/2013

Stephen C. Yang, MD

None

None

None

None

6/18/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved